Oncology Pharma stock (ONPH) is up 24% over the past month: here is where to buy it

Oncology Pharma stock (ONPH) has been on the rise for the past month and today it is up by over 15%.

The recent bullish trend has attracted lots of investors especially as some tech stocks like Meta dip.

Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

To help stock traders eying the Oncology Pharma stock (ONPH), Invezz has created a brief article on what it is and the best places to trade it.

To find out more, please continue reading.

Best places to trade ONPH Stock

eToro

eToro is one of the world’s leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It’s social copy trading features make it a great choice for those getting started.

Register with eToro instantly

Disclaimer

Webull

Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.

Register with Webull instantly

What is Oncology Pharma stock (ONPH)?

Oncology Pharma stock (ONPH) is the stock for Oncology Pharma, Inc. and it is listed on OTC Markets Group under the ticker OTCMKTS: ONPH.

In a nutshell, Oncology Pharma, Inc. is an American pharmaceutical company that operates as an Oncology company. It develops, manufactures, and commercializes therapeutics for cancer patients. It is headquartered in San Francisco California.

Oncology Pharma has partnered with NanoSmart®Pharmaceuticals Inc. for its “innovative” drug delivery platform that targets several types of diseases including cancer.

One of the main breakthroughs of NanoSmart’s® platform technology is a “patented”(US 7,799,327 and EU 1706145 B1) human-derived, antinuclear antibody (ANA) that targets necrosis areas present in cancerous tumors and it is one of the most commonly used anti-cancer drugs.

Oncology Pharma was founded in 1993 by Marcel van Heesewijk.

Should I buy the ONPH stock today?

If you want to invest in a pharmaceutical-oriented stock that is on the rise, then the ONPH could be a good choice.

Nonetheless, the ONPH has been down since February 2000 and analysts do not expect the current bull market to persist for long.

ONPH stock price prediction

It is difficult to provide a precise price prediction of the ONPH stock because of the long bear market.

Nevertheless, there are anticipations that the ONPH stock could get above $6 in February.

$ONPH stock social media coverage